Related content

Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent

By Amadori S.   Fenaux P.   Ludwig H.   O'Dwyer M.   Sanz M.  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 403-412

Informa Healthcare

Access to resources Recommend Favorite

Cefepime-induced encephalopathy in patients with haematological malignancies: Clinical features and risk factors

By Ugai Tomotaka   Morisaki Kurimi   Tsuda Kenji   Sugihara Hiroyuki   Nishida Yuhki   Yamakura Masayuki   Takeuchi Masami   Matsue Kosei  

Scandinavian Journal of Infectious Diseases, Vol. 46, Iss. 4, 2014-04 ,pp. : 272-279

Informa Healthcare

Access to resources Recommend Favorite

What is known and unknown about chemotherapy‐related cognitive impairment in patients with haematological malignancies and areas of needed research

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 835-846

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nature and nurture: a case of transcending haematological pre‐malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B‐cell proliferations

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 391-400

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection

By Cherif Honar   Axdorph Ulla   Kalin Mats   Björkholm Magnus  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 112-116

Informa Healthcare

Access to resources Recommend Favorite